Posted on: Nov 10, 2017 02:52AM
I just heard a news story today via CBS that women with the "most common type of breast cancer" at Dx have a 40% risk of it recurring as much as 20 years later. They did not say the type but i thought this was just a real downer. Anyone on here planning hormonal therapy past 10 years?
Posts 31 - 35 (35 total)
Mar 12, 2018 04:50PM Traveltext wrote:
"What if the lymph nodes rather than afocus of spread - where actually like all lymph activity - a manner of trying to contain disease?"
Wildplaces, this may not be so far-fetched. The fact that bc patients with LN involvement don't all go on to develop mets is a significant point. Distant recurrence has so many individual factors that one answer why this is so may never be found in the days of individual treatment, individual prognoses become surely as important.
Sara536, I focus on living, but I'm certainly interested in how my dying might come about. A bit morbid, perhaps, but at the end of the day I don't have too much control of my medical future.
Dx 03/14, IBC, Lgth. 2cm, Stge IIIB, Gde 2B, ER+/PR+, HER2- ; FEC x3, Taxol x3; Mx & 2/23 nodes; Rads x 33; now on tamoxofin.
Mar 12, 2018 06:51PM Wildplaces wrote:
Sara - you are correct.😊 If you are hoping to get more attention to the baby as well as the bath water I think there is a name for it - integrative medicine - Paget called it SOIL and I being a gardener love that term.
It helps to understand the reasons behind it.
First it is useful to separate medicine - your doctor, your night nurse or your researcher from healthcare - pharmaceutical companies, hospital appointment systems, care policies, tonnes of paperwork, computer systems that are not well integrated, pharmacy funding.
(Something as simple as car parking availability being crappy can completely throw an elderly patient or some one with disability, or a mother who brought her young child with her off - by the time they have managed to scramble through corridors and lifts to a consult room any cohesive thought has vanished. Bringing a buddy partially rezolves that but not everyone can and if oncology app are three monthly - out goes the opportunity to be heard for half a year.)
Although the two must function as one in individual treatment, they have different aims and priorities.
Oncology, psychiatry and age care is heavily under represented in healthcare - although I think USA is catching up on cancer because of the sheer volume of numbers that need care.
And in the above fields medicine has also been underfunded and burdened with death more so than in other specialties - there are areas where much work is needed and overdue.
Given what they see everyday - I think oncologists are eternal optimists.
To return to the thread question - it would be a YES for me ( I am 49)if I can hold steady in the side effects profile. There are tests that help you gage how you are doing with those. Ask me in 5 years and my personal take on the " evidence" might be different.
Mar 12, 2018 10:35PM Amelia01 wrote:
Interesting read but my MO has said that they've known for quite some time that lymph node involvement isn't a precursor to spread (or maybe that is what she tells me to make me feel better). What would be interesting is to know for those who were diagnosed as stage 4 with mets if lymph nodes were also involved. I would imagine that there are few node negative stage 4s.
It also should debunk the exclusion of oncotype testing for node positive, wouldn't it?